Update: HIMSS20 has been canceled due to the coronavirus. Read more here.
About the author: Naomi Fried, PhD, is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation-program design and optimization consulting to healthcare stakeholders including pharma, payers and providers. Her previous positions include the first chief innovation officer at Boston...
Editor's note: This story has been updated with information from Verily's announcement of the clearance.
Verily, the life sciences research subsidiary of Alphabet, has received FDA 510(k) clearance for an augmented version of its prescription Study Watch wearable that includes some form of arrhythmia monitoring.
The Study Watch With Irregular Pulse Monitor is classified by the FDA as a “...
Following news of hardships at Proteus Digital Health, CEO Andrew Thompson has told STAT News that the company is winding down its high-profile $88 million deal with Otsuka Pharmaceutical, and will be pivoting from its current primary focus on mental disorders toward cancers and infectious disease treatments.
The pharmaceutical company has now acquired the full license for Proteus’ mental health...
German pharma giant Bayer and British biotech firm Exscientia have announced a three-year partnership focused on the use of Artificial Intelligence in cardiovascular and oncology drug discovery.
The collaboration will initially see the companies work on three early-stage research projects, combining Bayer’s data and drug discovery capabilities and Exscientia’s Centaur Chemist platform.
According...
Editor's note: This story has been updated with additional statements from Pear Therapeutics.
Pear Therapeutics pulled back the curtain this morning on a number of new deals between the prescription digital therapeutics maker and other tech companies or researchers.
Ranging from virtual reality therapies to voice biomarker tech, the moves appear to be an effort from Pear to add new products to...
Stockholm-based respiratory health startup NuvoAir is set to make its technology available in selected cystic fibrosis (CF) centres after entering a new partnership with Roche Italy.
This marks NuvoAir’s first CF deal with a pharma company.
WHY IT MATTERS
According to the UK-based Cystic Fibrosis Trust, the genetic condition is estimated to affect around 100,000 people globally. It causes a...
MobiHealthNews’ parent company HIMSS and Forrester Research announced today a new research partnership that will survey health system leadership on digital health adoption and measure its impact on patient experience and physician burnout. These findings will be presented at March’s HIMSS Global Health Conference & Exhibition in Orlando.
“Uncovering emerging strategies for quantifying...
It has been a tumultuous week in the realm of digital health partnerships. It started with word of Proteus Digital Health’s floundering business and failed investment round, which reports say was partially driven by cooling relations between the digital pill maker and its longtime patron Otsuka Pharmaceuticals. A few days later, Sanofi announced a company-wide strategy shift that found Onduo, its...
About eight month after its unveiling, Express Scripts has now revealed the companies and programs it is including in the inaugural cohort of its digital health formulary — the first such resource from a pharmacy benefits manager designed to help clients review vetted digital health programs.
The formulary is comprised of 15 clinically validated digital health programs addressing the management...
Amazon’s PillPack has struck a deal with Blue Cross Blue Shield of Massachusetts that integrates the former’s digital pharmacy platform into the payer’s MyBlue member app.
As part of the agreement Blue Cross members will have the option to switch their prescriptions over to PillPack directly from the MyBlue app without having to reenter their insurance details or medication list.
Members will...
